期刊文献+

CIK细胞中CD4^+T细胞亚群抗肿瘤免疫活性 被引量:9

Antitumor Immunity of CD4^+ T Cells Subset in CIKs
暂未订购
导出
摘要 目的 :观察CIK细胞中CD4 + T细胞亚群抗肿瘤免疫活性。方法 :体外大规模扩增CIK细胞 ,利用磁珠分离系统富集纯化CIK细胞中的CD4 + T细胞亚群。采用胞内染色法分析其中Th1/Th2的比例变化 ;LDH法和荧光染色法比较 4h和 2 0h其对raji细胞的杀伤率和raji凋亡。 结果 :经磁珠分离法富集的CD4 + CIK细胞纯度高达 96 % ,其中Th1/Th2的分布较PBMC有显著的改变 :Th1亚群、Th0亚群明显升高 ,Th2亚群无显著变化。CD4 + CIK细胞虽然不能在 4h之内溶解raji细胞 ,但可在 2 0h时产生同CD4 -CIK细胞同样强大的杀伤活性 ,荧光染色可见其在 4h之内诱导raji出现早期凋亡的迹象。 结论 :本研究提示CD4 + CIK细胞具有明显的“Th1优势”可以调节宿主免疫细胞活性 ;同时CD4 + CIK细胞可通过诱导肿瘤细胞凋亡实现对肿瘤的抑制和杀伤。 Objective: To observe antitumor immunity of CD4+ T cells subset in CIKs. Methods: After large scale of amplification in vitro, CD4+ T cells subset in CIKs was isolated by magnetic beads separation columns. Distribution of Th1/ Th2 in CD4+ T cells subset in CIKs was analysized by intracellular cytokine staining. Cytotoxicity of purified CD4+ T cells subset in CIKs against raji cells and apoptosis of raji cells after 4 h and 20 h coculture were determined by LDH method and fluorescent staining method. Results: Purity of enriched CD4+ T cells subset in CIKs reached 96%. Comparing with PBMCs, significant increase in Th1 subset and Th0 subset were observed but no statistical differences were found in Th2 subset. Few raji cells were lysed by CD4+ T cells subset in CIKs after 4 h co-incubation. But after 20 h co-incubation, the same effective lysis of raji cells as CD4- T cells subset was obtained in CD4+ T cells subset in CIKs. Fluorescent staining showed that CD4+ T cells subset in CIKs induced apoptosis of raji after 4 h coculture. Conclusion: The present study suggested that CD4+ T cells in CIKs were not only regulatory cells capable of modulating host immune system, but also immune effectors capable of inducing apoptosis in tumor cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2003年第2期126-129,共4页 Chinese Journal of Cancer Biotherapy
基金 天津科委自然科学基金资助项目 (项目编号02 3 6110 11)
关键词 CIK细胞 CD4^+T细胞亚群 抗肿瘤 免疫活性 CIK CD4+ T cells subset antitumor immunity Th1 dominance apoptosis
  • 相关文献

参考文献8

  • 1于津浦,任秀宝,张澎,安秀梅,张乃宁,郝希山.恶性实体瘤患者自体CIK细胞的体外大量扩增与生物学指标检测[J].中国肿瘤生物治疗杂志,2001,8(3):215-216. 被引量:36
  • 2Lu PH, Negrin BS. A novel population of expanded human CD3^+ CD56^+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency [ J ]. J Immunol, 1994, 153(4): 1687-1696.
  • 3Schmidt-Wolf GD, Negrin RS, Schmidt - Wolf IG. Activated T cells and cytokine-induced CD3^+ CD56^+ killer cells[ J ]. Ann Hematol, 1997, 74(2) : 51-56.
  • 4Hoyle C, Bangs CD, Negrin BS, et al. Expansion of Philadelphia chromosome - negative CD3^+ CD56^+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice [ J ]. Blood, 1998, 92(9) : 3318-3327.
  • 5Schmidt-Wolf IG, Finke S, Huhn D, et al. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer,colorectal cancer and lymphoma[J]. Br J Cancer, 1999, 81(6) :1009-1016.
  • 6Margolin KA, Negrin BS, Forman SJ, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy[J].Immunol Rev, 1997, 157: 231-240.
  • 7Kayagaki N, Yamaguchi N, Nakayama M, et al. Involvement of TNF-related apoptosis inducing ligand in human CD4^+ T cell-mediated cytotoxicity[ J]. J Immunol, 1999, 162 : 2639-2647.
  • 8Jeremias I, Herr I, Boehler T, et al. TRAIL-APO-2-1igand-induced apoptosis in human T cells[J]. Eur J Immunol, 1998, 28:143-152.

二级参考文献4

  • 1[1]Lu PH, Negrin RS. A novel population of expanded human CD3 + CD56 + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994, 153(4): 1687-1696.
  • 2[2]Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3 + CD56 + killer cells [ J ]. Ann Hematol, 1997, 74(2): 51-56.
  • 3[3]Hoyle C, Bangs CD, Negrin RS, et al. Expansion of philadelphia chromosome-negative CD3 + CD56 + cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice [ J ]. Blood, 1998, 92(9): 3318-3327.
  • 4[4]Margolin KA, Negrin RS, Forman SJ, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy[ J ].Immunol Rev, 1997, 157: 231-240.

共引文献35

同被引文献79

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部